- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01130974
A Study to Assess the Safety and Efficacy of a Daily Disposable Contact Lens
November 8, 2013 updated by: Bausch & Lomb Incorporated
The objective of this study is to evaluate the safety and efficacy of the Bausch & Lomb daily disposable tint contact lens (Test) compared to a currently marketed daily disposable cosmetic tint contact lens (Control).
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
200
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
New York
-
Rochester, New York, United States, 14609
- Bausch & Lomb
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Subjects must have clear central corneas and be free of any anterior segment disorders.
- Subjects must be adapted wearers of soft contact lenses, wear a lens in each eye, and each lens must be of the same manufacture and brand.
- Subjects must be correctable through spherocylindrical refraction to 32 letters (0.3 logMAR) or better (distance, high contrast) in each eye.
- Subjects must be of Asian descent.
- Subjects must require plano or myopic correction and must require contact lens correction from plano to -6.00 D in both eyes.
Exclusion Criteria:
- Subjects who have any systemic disease affecting ocular health.
- Subjects using any systemic or topical medications that will, in the Investigator's opinion, affect ocular physiology or lens performance.
- Subjects with an active ocular disease or are using any ocular medication.
- Subjects with any "Present" finding during the slit lamp examination that, in the Investigator's judgment, interferes with contact lens wear.
- Subjects with any scar or neovascularization within the central 4 mm of the cornea. Subjects with minor peripheral corneal scarring (that does not extend into the central area), that in the Investigator's judgment, does not interfere with contact lens wear, are eligible for this study.
- Subjects who currently wear monovision, multifocal, or toric contact lenses.
- Subjects who are adapted wearers of 1-Day Acuvue Define daily disposable cosmetic tint contact lenses.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Bausch & Lomb contact lens
Bausch & Lomb daily disposable cosmetic tint contact lens
|
Bausch & Lomb daily disposable cosmetic tint contact lens
|
|
Active Comparator: Marketed daily disposable contact lens
Marketed daily disposable cosmetic tint contact lens
|
Marketed daily disposable cosmetic tint contact lens
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Slit Lamp Findings
Time Frame: Summarized over all follow-up visits through 1 month
|
Graded Slit lamp findings (epithelial edema, epithelial microcysts, corneal staining, limbal injection, bulbar injection, upper lid tarsal conjunctival abnormalities, corneal neovascularization, and corneal infiltrates) > grade 2 over all follow-up visits, summarizes the worst case over all follow-up visits.
Graded 0-4 with 0=none and 4=severe
|
Summarized over all follow-up visits through 1 month
|
|
logMAR Visual Acuity (VA)
Time Frame: Summarized over all visits, and dispensed visit
|
Non-inferiority of distance high contrast logMAR lens VA.
A negative value indicates improved VA. Lens VA was established for All Study, Dispensed, 2-Week Follow-up Visit, and 1-Month Follow-up Visit
|
Summarized over all visits, and dispensed visit
|
|
logMAR Visual Acuity (VA)
Time Frame: 2 week and 1 month follow-up
|
Non-inferiority of distance high contrast logMAR lens VA.
A negative value indicates improved VA. Lens VA was established for All Study, Dispensed, 2-Week Follow-up Visit, and 1-Month Follow-up Visit
|
2 week and 1 month follow-up
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Lens Wettability
Time Frame: Summarized over all follow-up visits through 1 month
|
Lens wettability was rated as Grade 4-0.
Grade 4 = 100% of anterior surface wettable (optimal); Grade 3 = presence of small (< 0.1 mm), individual, discrete non-wetting areas (slight); Grade 2 = presence of single area of non-wetting between 0.1 mm and 0.5 mm in size (mild); Grade 1 = presence of several areas on non-wetting, each between 0.1 mm and 0.5 mm in size (moderate); Grade 0 = presence of one or more non-wetting areas > 0.5 mm in size (severe).
Suboptimal lens wettability was defined as a rating other than Grade 4, ie slight, mild, moderate, or severe ratings.
Over All Visits summarizes the worst case over the dispensing and all follow-up visits.
|
Summarized over all follow-up visits through 1 month
|
|
Lens Deposits
Time Frame: Summarized over all follow-up visits through one month
|
Degree of lens deposits was assessed as none, light, medium, or heavy.
Suboptimal lens deposits were defined as a degree rating of medium or heavy.
Measured over all visits through one month
|
Summarized over all follow-up visits through one month
|
|
Lens Centration
Time Frame: Summarized over all follow-up visits through 1 month
|
Lens centration was assessed as excellent(fully centered), good (slight decentration, no corneal exposure), fair (decentration, intermittent corneal exposure), or poor (incomplete corneal coverage and/or edge lift). Suboptimal lens centration was defined as a rating other than excellent. |
Summarized over all follow-up visits through 1 month
|
|
Lens Movement
Time Frame: Summarized over all follow-up visits through one month
|
Lens movement was assessed as adequate, excessive (> 0.6 mm), insufficient (< 0.2 mm), or adherence.
Suboptimal lens movement was defined as a rating other than adequate.
|
Summarized over all follow-up visits through one month
|
|
Symptoms & Complaints
Time Frame: Summarized over all follow-up visits through one month
|
Subject symptoms/complaints were assessed on a scale from 0 to 100, with 0 denoting least favorable symptoms/complaints and 100 being the most favorable score.
|
Summarized over all follow-up visits through one month
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Director: Bev Barna, Bausch & Lomb Incorporated
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
April 1, 2010
Primary Completion (Actual)
June 1, 2010
Study Completion (Actual)
September 1, 2010
Study Registration Dates
First Submitted
May 25, 2010
First Submitted That Met QC Criteria
May 25, 2010
First Posted (Estimate)
May 26, 2010
Study Record Updates
Last Update Posted (Estimate)
December 10, 2013
Last Update Submitted That Met QC Criteria
November 8, 2013
Last Verified
November 1, 2013
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 639
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Myopia
-
Tianjin Medical University Eye HospitalNot yet recruitingProgressive Myopia | Pediatric Myopia | Orthokeratology-related Myopia Progression
-
Shanghai General Hospital, Shanghai Jiao Tong University...Not yet recruitingMyopia | Myopia, ProgressiveChina
-
SightGlass Vision, Inc.Recruiting
-
University of FaisalabadCompletedRefractive Errors | Myopia | Progressive MyopiaPakistan
-
SightGlass Vision, Inc.RecruitingMyopia | Myopia Progression | Juvenile MyopiaUnited States
-
Shanghai Eye Disease Prevention and Treatment CenterEnrolling by invitationMyopia, Child Myopia ProgressionChina
-
He Eye HospitalNot yet recruiting
-
Zhongshan Ophthalmic Center, Sun Yat-sen UniversityActive, not recruiting
-
University Eye Hospital, FreiburgActive, not recruiting
-
University of BradfordUniversity of Huddersfield; CooperVision International Limited (CVIL)Enrolling by invitationMyopia, ProgressiveUnited Kingdom
Clinical Trials on Bausch & Lomb contact lens
-
Bausch Health Americas, Inc.Completed
-
Bausch & Lomb IncorporatedCompletedMyopiaUnited States
-
Bausch & Lomb IncorporatedCompletedMyopia and Hyperopia and PresbyopiaUnited States
-
Bausch & Lomb IncorporatedCompletedMyopiaUnited States
-
Bausch & Lomb IncorporatedCompleted
-
Bausch & Lomb IncorporatedCompletedContact Lens WearUnited States
-
Second Affiliated Hospital, School of Medicine,...UnknownCataract | Corneal Opacity | Lens Subluxation | Small Pupil | Hypermature CataractChina
-
Bausch & Lomb IncorporatedRecruiting
-
Alcon ResearchCompletedMyopia | AmetropiaUnited States
-
Alcon ResearchCompletedRefractive Errors | AmetropiaUnited States